Miller-Rich Nancy
- SEC CIK
- 0001735084
No open-market purchases or sales filed in the past year.
Current role at each company
- FDMT 4D Molecular Therapeutics, Inc.Directoras of Jun 18, 2026
- ALDX Aldeyra Therapeutics, Inc.Directoras of Jun 11, 2026
- ICPT Intercept Pharmaceuticals, Inc.Directoras of Nov 13, 2023
- KDMN Kadmon Holdings, Inc.Directoras of Nov 9, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Miller-Rich Nancy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALDX Aldeyra Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2024 (view filing) | May 3, 2021-Apr 12, 2023 | 1,267 daysLate | Miller-Rich NancyDirector | PPurchase | +922 | $11.33 | +$10.4K | New position922 after | 2 lots |